Yali Zhou
1 Zhiyuan Road
Guilin, 541199, China
Guilin, 541199, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Fludarabine, Busulfan, Thiotepa, and Melphalan: A Novel Low-Toxicity Myeloablative Conditioning Regimen for Haploidentical HSCT in Children and Adolescents Aged ≥7 Years With Transfusion-Dependent β-Thalassemia.
Journal: Pediatric blood & cancer
Published: March 11, 2026
Research progress on the microbiota-gut-brain axis in autism spectrum disorder: a narrative review.
Journal: Frontiers in microbiology
Published: March 06, 2026
Successful gene therapy for transfusion-dependent α-thalassemia: a case report.
Journal: Blood advances
Published: December 10, 2025
Luspatercept Treatment in a β-Thalassemia Patient with Pulmonary Arterial Hypertension: A Case Report.
Journal: Mediterranean journal of hematology and infectious diseases
Published: June 11, 2025
Haploidentical hematopoietic stem cell transplantation for the treatment of congenital dyserythropoietic anemia combined with thalassemia: a report of two cases.
Journal: Annals of hematology
Published: May 24, 2025
A Kindred With Dominantly Inherited β-Thalassemia (Hemoglobin Chesterfield) Showing a Therapeutic Efficacy of Luspatercept.
Journal: Pediatric blood & cancer
Published: March 18, 2025
Elevated Endogenous Alveolar Carbon Monoxide Concentration in Patients with Transfusion-Dependent Thalassemia and Its Relation with Ineffective Erythropoiesis.
Journal: Mediterranean journal of hematology and infectious diseases
Published: December 09, 2024
Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia.
Journal: Annals of hematology
Published: December 01, 2024
CDK5: Insights into its roles in diseases.
Journal: Molecular biology reports
Published: November 22, 2024
Anti-Mullerian Hormone Evaluates Ovarian Function in Patients with Non-Transfusion-Dependent Thalassemia.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 01, 2024
Exploring the Therapeutic Potential of Plumbagin: Its Current Applications in Cancer and Neuropsychiatric Disorders.
Journal: Current medicinal chemistry
Published: August 13, 2024
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports.
Journal: Frontiers in oncology
Published: August 08, 2024
Last Updated: 09/26/2026